Page last updated: 2024-12-07
monoacetoacetin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
monoacetoacetin: used as ketone body-carbohydrate substrate for parental feeding of rats [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 125624 |
SCHEMBL ID | 491497 |
MeSH ID | M0074137 |
Synonyms (4)
Synonym |
---|
monoacetoacetin |
butanoic acid, 3-oxo-, monoester with 1,2,3-propanetriol |
SCHEMBL491497 |
RMSNKXILWAAGDS-UHFFFAOYSA-N |
Research Excerpts
Effects
Excerpt | Reference | Relevance |
---|---|---|
"Monoacetoacetin (MAA) has been used experimentally as a physiological energy source in parenteral nutrition. " | ( Growth-inhibitory effects of the ketone body, monoacetoacetin, on human gastric cancer cells with succinyl-CoA: 3-oxoacid CoA-transferase (SCOT) deficiency. Hirakawa, K; Nishiguchi, Y; Ohira, M; Sawai, M; Yashiro, M, ) | 1.83 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 7 (63.64) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.30
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.30) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (13.33%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (86.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |